These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2547926)

  • 1. Kappa-opioid agonists do not inhibit adenylate cyclase.
    Makimura M; Murakoshi Y
    J Pharmacobiodyn; 1989 Mar; 12(3):125-31. PubMed ID: 2547926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa-opiate agonists inhibit adenylate cyclase and produce heterologous desensitization in rat spinal cord.
    Attali B; Saya D; Vogel Z
    J Neurochem; 1989 Feb; 52(2):360-9. PubMed ID: 2536070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of mu, delta, and kappa opioid agonists on adenylate cyclase activity.
    De Montis GM; Devoto P; Preti A; Tagliamonte A
    J Neurosci Res; 1987; 17(4):435-9. PubMed ID: 2887665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate-inhibited adenylate cyclase in rat brain membranes depleted of Gs-stimulated adenylate cyclase.
    Childers SR
    J Neurochem; 1988 Feb; 50(2):543-53. PubMed ID: 2826699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266.
    Frey HH
    Pharmacol Toxicol; 1988 Mar; 62(3):150-4. PubMed ID: 2836842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions.
    Chang HM; Berde CB; Holz GG; Steward GF; Kream RM
    Anesthesiology; 1989 Apr; 70(4):672-7. PubMed ID: 2467589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at mu- and kappa-opioid receptor sites in rabbit and guinea-pig cerebellum membranes.
    Frances B; Moisand C; Meunier JC
    Eur J Pharmacol; 1985 Nov; 117(2):223-32. PubMed ID: 2866971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid control of the ruminant stomach motility: functional importance of mu, kappa and delta receptors.
    Ruckebusch Y; Bardon T; Pairet M
    Life Sci; 1984 Oct; 35(17):1731-8. PubMed ID: 6090847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
    Vaupel DB; Cone EJ; Johnson RE; Su TP
    J Pharmacol Exp Ther; 1990 Jan; 252(1):225-34. PubMed ID: 2153801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein.
    Lawrence DM; Bidlack JM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1678-83. PubMed ID: 8103800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. kappa-Opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatments.
    Avidor-Reiss T; Zippel R; Levy R; Saya D; Ezra V; Barg J; Matus-Leibovitch N; Vogel Z
    FEBS Lett; 1995 Mar; 361(1):70-4. PubMed ID: 7890042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
    Li JG; Zhang F; Jin XL; Liu-Chen LY
    J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mu type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to G-protein-mediated inhibition of adenylyl cyclase.
    Fedynyshyn JP; Lee NM
    FEBS Lett; 1989 Aug; 253(1-2):23-7. PubMed ID: 2547657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential agonist regulation of the human kappa-opioid receptor.
    Blake AD; Bot G; Li S; Freeman JC; Reisine T
    J Neurochem; 1997 May; 68(5):1846-52. PubMed ID: 9109509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.